
Charles Stephen Foster MD
Cataract Related, Cornea & External Disease, Refractive Surgery, Uveitis
President and CEO, Massachusetts Eye Research and Surgery Institution (MERSI) Professor, Part-Time, Department of Ophthalmology at Harvard Medical School Founder and Chairman of the Board, Ocular Immunology and Uveitis Foundation
Join to view full profile
1440 Main StSte 201Waltham, MA 02451
Phone+1 781-891-6377
Fax+1 617-494-1430
Dr. Foster is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 1975 - 1977
Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 1975 - 1976
Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1972 - 1975
Duke University HospitalInternship, Internal Medicine, 1969 - 1970
Duke University School of MedicineClass of 1969
Certifications & Licensure
MA State Medical License 1975 - 2025
NY State Medical License 2006 - 2020
FL State Medical License 2017 - 2019
NC State Medical License 1969 - 1992
MD State Medical License 1970 - 1988
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2017
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013-2017
- Life Fellow Award Academy of Ophthalmology, 2012
Clinical Trials
- Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis Start of enrollment: 2017 Mar 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsOutcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.Lisa Kongrat, Arash Maleki, Ploysai Rujkorakarn, Michael J Margolis, Tate Valerio
Ocular Immunology and Inflammation. 2026-07-01 - Correction: Appraisal of vitreous syphilis antibody as a novel biomarker for the diagnosis of syphilitic uveitis: a prospective case-control study.Sukhum Silpa-Archa, Tararat Hoopholerb, Charles Stephen Foster
Eye. 2026-06-01 - 2 citationsIncidence and Outcome of Cataract in Eyes with Scleritis and Episcleritis.Michelle J Sun, Bernard A Rosner, Craig W Newcomb, Kurt A Dreger, Pichaporn Artornsombudh
Ocular Immunology and Inflammation. 2025-09-01
Journal Articles
- Use of intravitreal rituximab for treatment of vitreoretinal lymphomaLarkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR, British Journal of Ophthalmology, 1/1/2014
- Anterior chamber intraocular lens implantation in patients with a history of chronic uveitis: Five-year follow-upSuelves AM, Siddique SS, Schurko B, Foster CS, Journal of Cataract and Refractive Surgery, 1/1/2014
- Rashid KA, Foster CS, Ahmed AR, Investigative Ophthalmology & Visual Science, 11/1/2013
External Links
- Uveitis.orghttp://Www.uveitis.org
- MERSIhttp://Www.mersi.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









